Skip to main content

Table 3 Mean difference in primary and secondary outcome at T0 (baseline), T1 (after intervention) and T2 (follow-up) in the experimental/control groups

From: Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial

Variable Group T0
M (SD)
T1
M (SD)
p value T2
M (SD)
p value
Depression Experimental 21.16 (4.83) 15.58 (8.50) 0.025a 12.83 (88.21) 0.016b
Control 22.66 (5.34) 23.16 (8.89) 0.969a 25.75 (8.22) 0 .285b
p value 0.416c 0.073c   0.006c  
CE regulation Experimental 105 (14.72) 108.41 (15.80) 0.442a 111.08 (23.30) 0.480b
Control 108 (13.08) 111.58 (11.56) 0.102a 110.16 (7.76) 0.656b
p value 0.644c 0.644c   0.908c  
M C beliefs Experimental 79.51 (10.72) 72.66 (11.42) 0.050a 68.72 (15.74) 0.006b
Control 76.33 (12.08) 76.01 (11.62) 0.769a 77/91 (12.94) 0.906b
p value 0.506c 0.488c   0.088c  
  1. aWilcoxon test
  2. bWilcoxon test (compare T0 to T2)
  3. cMann Whitney test